Milk Supplementation and Bone Health in Children

NCT ID: NCT05074836

Last Updated: 2021-10-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

254 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-09-03

Study Completion Date

2022-12-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Objectives: to examine the effects of a Yili child formula milk and regular milk on bone health and growth in young children.

Study design: cluster randomized controlled trial.

Setting: kindergartens in Hui-ning County of Gansu Province, China (north west).

Participants: \>=246 apparent healthy children aged 4-6 years old.

Interventions:

(I) Yili child formula milk (QQ star formula, SCI-PRO NUTR5+6TM), 195 ml \*2 /day; (II) Yili regular milk (pure milk), 195ml\*2 /day; (III) Controls: about 50g/d grain foods (containing 20-30 g carbohydrates), e.g. bread.

Interventional Duration: 12 months.

Outcome measures: determined at 0, 6 and 12 months post treatments. Primary outcomes: bone density and bone mineral contents at the forearm and heel, bone biomarkers.

Secondary outcomes: (1) anthropometric indices: weight, height, waist circumference, etc.; (2) immune status.

Other measures: dietary intakes, physical activities, general information, medical information, adverse of side effects.

Data Analyses: The one-year changes and percent changes in the primary and secondary outcomes will be compared among the 3 groups.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Bone Density Increased Body Height

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

SINGLE

Outcome Assessors
The two milk products have the same-looking package and similar taste.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Formula Milk

Formula milk designed for young children aged over 3 years;

Dosage: 195 ml/time;

Frequence: 2 times /day;

Duration: 12 months

Group Type EXPERIMENTAL

Formula milk

Intervention Type DIETARY_SUPPLEMENT

Brand name: Yili (QQ star formula milk);

Type: SCI-PRO NUTRI 5+6TM formula milk designed for young children aged over 3 years;

Dosage: 195ml\*2/d;

Intervention duration: 12 months

Regular milk

Regular milk (pure milk);

Dosage: 195 ml/time;

Frequence: 2 times /day;

Duration: 12 months

Group Type ACTIVE_COMPARATOR

Regular milk

Intervention Type DIETARY_SUPPLEMENT

Brand name: Yili;

Type: regular milk (pure milk);

Dosage: 195ml\*2/d;

Intervention duration: 12 months

Control foods

Grain foods: e.g., bread;

Dosage: 20-40 g/time;

Frequence: 2 times /day;

Duration: 12 months

Group Type OTHER

Control foods

Intervention Type OTHER

Brand: N/A;

Food type: grain foods (e.g., bread);

Dosage: 20-40g \* 2/d grain foods

Intervention duration: 12 months

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Formula milk

Brand name: Yili (QQ star formula milk);

Type: SCI-PRO NUTRI 5+6TM formula milk designed for young children aged over 3 years;

Dosage: 195ml\*2/d;

Intervention duration: 12 months

Intervention Type DIETARY_SUPPLEMENT

Regular milk

Brand name: Yili;

Type: regular milk (pure milk);

Dosage: 195ml\*2/d;

Intervention duration: 12 months

Intervention Type DIETARY_SUPPLEMENT

Control foods

Brand: N/A;

Food type: grain foods (e.g., bread);

Dosage: 20-40g \* 2/d grain foods

Intervention duration: 12 months

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Aged between 4-6 years;
* female and male
* Can be enrolled into kindergarten/school as a normal child.
* Be willing to drinking milk daily.

Exclusion Criteria

* Milk allergy or intolerance, did not to be used to drinking milk;
* Had the following diseases/conditions confirmed by a hospital: serious diseases of heart, liver, kidney, brain, hematopoietic system, immunity, thyroid or cancer that need to be hospitalization for more than 1 week or take medication(s) for more than 1 month with the past two years.
* having infectious diseases, e.g., tuberculosis, hepatitis, etc.
* Taking vitamin D, calcium tables or nutrient package;
* Consumed more than 3 times (\>600ml) milk each week in the previous month.
* Be not willing to provide informed consent, or have other conditions that were considered to be unsuitable for the study by the investigators.
* Increases of body health were out of the range between 5-8 cm in the last year.
Minimum Eligible Age

48 Months

Maximum Eligible Age

83 Months

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

LanZhou University

OTHER

Sponsor Role collaborator

Sun Yat-sen University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Yu-ming Chen

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Yuming Chen, Ph.D.

Role: PRINCIPAL_INVESTIGATOR

Sun Yat-sen University

Zhifu Zhao, M. Phil

Role: STUDY_CHAIR

Inner Mongolia Dairy Technology Research Institute Co., Ltd.

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Lanzhou University

Lanzhou, Gangshu, China

Site Status

Countries

Review the countries where the study has at least one active or historical site.

China

References

Explore related publications, articles, or registry entries linked to this study.

Zhao ZF, Li BY, He Q, Hao JY, Zhang KS, Zhang B, Hu W, Feng HT, Szeto IM, Chen YM, Zhang GX, Tang XY. Impact of dairy supplementation on bone acquisition in children's limbs: a 12-month cluster-randomized controlled trial and meta-analysis. Arch Osteoporos. 2024 Jul 24;19(1):65. doi: 10.1007/s11657-024-01422-2.

Reference Type DERIVED
PMID: 39043915 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

SYSU-51000-20210723-0001

Identifier Type: -

Identifier Source: org_study_id